Biodyne Statistics

Total Valuation

Biodyne has a market cap or net worth of KRW 534.86 billion. The enterprise value is 514.81 billion.

Market Cap	534.86B
Enterprise Value	514.81B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Biodyne has 29.76 million shares outstanding. The number of shares has decreased by -30.18% in one year.

Current Share Class	n/a
Shares Outstanding	29.76M
Shares Change (YoY)	-30.18%
Shares Change (QoQ)	-0.97%
Owned by Insiders (%)	46.56%
Owned by Institutions (%)	1.14%
Float	15.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	125.47
PB Ratio	12.28
P/TBV Ratio	n/a
P/FCF Ratio	1,337.41
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-576.64
EV / Sales	122.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1,287.27

Financial Position

The company has a current ratio of 17.92, with a Debt / Equity ratio of 0.00.

Current Ratio	17.92
Quick Ratio	17.41
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	0.02
Interest Coverage	-11,653.89

Financial Efficiency

Return on equity (ROE) is -2.05% and return on invested capital (ROIC) is -2.94%.

Return on Equity (ROE)	-2.05%
Return on Assets (ROA)	-2.87%
Return on Capital (ROIC)	-2.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	4.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.01%
50-Day Moving Average	18,557.60
200-Day Moving Average	17,312.00
Relative Strength Index (RSI)	45.85
Average Volume (20 Days)	1,043,785

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biodyne had revenue of KRW 4.20 billion and -892.77 million in losses. Loss per share was -30.47.

Revenue	4.20B
Gross Profit	921.10M
Operating Income	-2.05B
Pretax Income	-1.11B
Net Income	-892.77M
EBITDA	-402.02M
EBIT	-2.05B
Loss Per Share	-30.47

Full Income Statement

Balance Sheet

The company has 20.06 billion in cash and 6.83 million in debt, giving a net cash position of 20.05 billion or 673.64 per share.

Cash & Cash Equivalents	20.06B
Total Debt	6.83M
Net Cash	20.05B
Net Cash Per Share	673.64
Equity (Book Value)	43.14B
Book Value Per Share	1,463.39
Working Capital	20.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 991.85 million and capital expenditures -591.93 million, giving a free cash flow of 399.92 million.

Operating Cash Flow	991.85M
Capital Expenditures	-591.93M
Free Cash Flow	399.92M
FCF Per Share	13.44

Full Cash Flow Statement

Margins

Gross margin is 21.95%, with operating and profit margins of -48.88% and -21.28%.

Gross Margin	21.95%
Operating Margin	-48.88%
Pretax Margin	-26.48%
Profit Margin	-21.28%
EBITDA Margin	-9.58%
EBIT Margin	-48.88%
FCF Margin	9.53%

Dividends & Yields

Biodyne does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	30.18%
Shareholder Yield	30.18%
Earnings Yield	-0.17%
FCF Yield	0.07%

Stock Splits

The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Feb 28, 2024
Split Type	Forward
Split Ratio	5

Scores

Biodyne has an Altman Z-Score of 161.32.

Altman Z-Score	161.32
Piotroski F-Score	n/a